Glucose and glucagon do stimulate somatostatin release from isolated pancreatic islets

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval.

The journal of prevention of Alzheimer's disease·2023

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events.

Diabetes & metabolism·2017

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

Diabetes & metabolism·2017

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).

Diabetes & metabolism·2017

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1).

Diabetes, obesity & metabolism·2015

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).

Diabetes, obesity & metabolism·2015

Metabolic and macrovascular outcomes following simultaneous pancreas-kidney transplantation and kidney transplantation alone in recipients with type 1 diabetes mellitus: a systematic review and meta-analysis.

Diabetologia·2026

Rotavirus vaccination and incidence of type 1 diabetes: a population-based natural experiment.

Diabetologia·2026

A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes.

Diabetologia·2026

Divergent complication patterns of type 2 diabetes in African individuals who are lean versus overweight or obese: a multi-cohort analysis.

Diabetologia·2026

Pancreatic islets: new discoveries for innovative treatments of diabetes?

Diabetologia·2026

Dulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA).

Diabetologia·2026

[Anatomical variations of peripancreatic veins and surgical strategies].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2026

M4 drug discovery: Human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonist.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

Intranasal delivery of Semaglutide using a thermoresponsive PNPHO nanocarrier: formulation development, characterization and biological evaluation.

International journal of pharmaceutics·2026

Clinical Implementation of Pharmacogenetics-Based Machine Learning Clinical Decision Support Systems: A Scoping Review.

Applied clinical informatics·2026

Substance use-related stigma and injection-related bacterial infections among people who inject drugs in Montreal.

The International journal on drug policy·2026

Real-world adherence and healthcare resource utilization following transition to aripiprazole once-every-2-months from oral or once-monthly aripiprazole among patients diagnosed with schizophrenia in the United States.

Current medical research and opinion·2026

Related Experiment Videos

Glucose and glucagon do stimulate somatostatin release from isolated pancreatic islets

Related Concept Videos

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval.

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events.

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1).

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).

Metabolic and macrovascular outcomes following simultaneous pancreas-kidney transplantation and kidney transplantation alone in recipients with type 1 diabetes mellitus: a systematic review and meta-analysis.

Rotavirus vaccination and incidence of type 1 diabetes: a population-based natural experiment.

A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes.

Divergent complication patterns of type 2 diabetes in African individuals who are lean versus overweight or obese: a multi-cohort analysis.

Pancreatic islets: new discoveries for innovative treatments of diabetes?

Dulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA).

[Anatomical variations of peripancreatic veins and surgical strategies].

M4 drug discovery: Human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonist.

Intranasal delivery of Semaglutide using a thermoresponsive PNPHO nanocarrier: formulation development, characterization and biological evaluation.

Clinical Implementation of Pharmacogenetics-Based Machine Learning Clinical Decision Support Systems: A Scoping Review.

Substance use-related stigma and injection-related bacterial infections among people who inject drugs in Montreal.

Real-world adherence and healthcare resource utilization following transition to aripiprazole once-every-2-months from oral or once-monthly aripiprazole among patients diagnosed with schizophrenia in the United States.

Related Experiment Videos

Glucose and glucagon do stimulate somatostatin release from isolated pancreatic islets

Related Concept Videos

Related Articles